دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
A decisive moment for The World Bank
doi : 10.1016/S0140-6736(23)00434-8
Volume 401, Issue 10378, 4–10 March 2023, Page 705
The end of the beginning: progress and next steps in KRAS-mutant non-small-cell lung cancer
*Sarah B Goldberg, Roy S Herbst
doi : 10.1016/S0140-6736(23)00288-X
Volume 401, Issue 10378, 4–10 March 2023, Pages 706-707
The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered
*Alexander Egeberg, Jacob P Thyssen
doi : 10.1016/S0140-6736(23)00059-4
Volume 401, Issue 10378, 4–10 March 2023, Pages 708-710
The use of cell-free DNA technology in pregnancy loss
Lorraine Dugoff
doi : 10.1016/S0140-6736(23)00182-4
Volume 401, Issue 10378, 4–10 March 2023, Pages 710-712
Towards a world with no child marriage: four countries pledge action
Fazilatun Nessa Indira, Gisèle Ndaya Luseba, Ergogie Tesfaye, Pauline Kedem Tallen
doi : 10.1016/S0140-6736(23)00109-5
Volume 401, Issue 10378, 4–10 March 2023, Pages 712-713
The therapeutic potential of psychedelics: the European regulatory perspective
Florence Butlen-Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp, Taina Mattila, Ewa Bałkowiec-Iskra, Georgios Aislaitner, Pavel Balabanov, Johan Lundberg, Dea Siggaard Stenbæk, Andre Elferink, Gitte M Knudsen, Steffen Thirstrup
doi : 10.1016/S0140-6736(23)00264-7
Volume 401, Issue 10378, 4–10 March 2023, Pages 714-716
Offline: The willing versus the legitimate
Richard Horton
doi : 10.1016/S0140-6736(23)00439-7
Volume 401, Issue 10378, 4–10 March 2023, Page 717
New leadership for Gavi
John Zarocostas
doi : 10.1016/S0140-6736(23)00435-X
Volume 401, Issue 10378, 4–10 March 2023, Page 718
Experts warn over potential for measles in Ukraine
Ed Holt
doi : 10.1016/S0140-6736(23)00436-1
Volume 401, Issue 10378, 4–10 March 2023, Page 719
Seeking solutions to global drugs shortages
Ferry Biedermann
doi : 10.1016/S0140-6736(23)00437-3
Volume 401, Issue 10378, 4–10 March 2023, Pages 720-721
Mishal Khan: challenging inequitable status quos in global health
Rachael Davies
doi : 10.1016/S0140-6736(23)00407-5
Volume 401, Issue 10378, 4–10 March 2023, Page 722
Healing Long Covid: a marathon not a sprint
Nisreen A Alwan
doi : 10.1016/S0140-6736(23)00408-7
Volume 401, Issue 10378, 4–10 March 2023, Pages 723-724
Legacies of eugenics
Delan Devakumar, Rochelle Burgess
doi : 10.1016/S0140-6736(23)00330-6
Volume 401, Issue 10378, 4–10 March 2023, Page 725
Ralph Lewis Sacco
Geoff Watts
doi : 10.1016/S0140-6736(23)00409-9
Volume 401, Issue 10378, 4–10 March 2023, Page 726
Addressing the effects of the earthquakes on Türkiye's health-care system
Olivier Uwishema
doi : 10.1016/S0140-6736(23)00326-4
Volume 401, Issue 10378, 4–10 March 2023, Page 727
The resurgence of dengue epidemic and climate change in India
Nitish Mondal
doi : 10.1016/S0140-6736(23)00226-X
Volume 401, Issue 10378, 4–10 March 2023, Pages 727-728
The human rights to water and sanitation, gender equality, and the State
Léo Heller
doi : 10.1016/S0140-6736(23)00100-9
Volume 401, Issue 10378, 4–10 March 2023, Page 728
When was mpox a public health emergency?
Stephen A Hoption Cann
doi : 10.1016/S0140-6736(23)00142-3
Volume 401, Issue 10378, 4–10 March 2023, Page 729
GBD 2019 study informs industry yet crucial questions remain unanswered
Tim Rycroft
doi : 10.1016/S0140-6736(22)02476-X
Volume 401, Issue 10378, 4–10 March 2023, Pages 729-730
GBD 2019 study informs industry yet crucial questions remain unanswered
John Thorley
doi : 10.1016/S0140-6736(22)02468-0
Volume 401, Issue 10378, 4–10 March 2023, Page 730
GBD 2019 study informs industry yet crucial questions remain unanswered
Nick Allen
doi : 10.1016/S0140-6736(23)00317-3
Volume 401, Issue 10378, 4–10 March 2023, Page 731
GBD 2019 study informs industry yet crucial questions remain unanswered – Authors' reply
Jeffrey D Stanaway, Simon I Hay, *Christopher J L Murray
doi : 10.1016/S0140-6736(22)02458-8
Volume 401, Issue 10378, 4–10 March 2023, Pages 731-732
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
Adrianus Johannes de Langen, Melissa L Johnson, Julien Mazieres, Anne-Marie C Dingemans, Giannis Mountzios, Miklos Pless, Jürgen Wolf, Martin Schuler, Hervé Lena, Ferdinandos Skoulidis, Yasuto Yoneshima, Sang-We Kim, Helena Linardou, Silvia Novello, Anthonie J van der Wekken, Yuanbin Chen, Solange Peters, Enriqueta Felip, Benjamin J Solomon, Suresh S Ramalingam, Christophe Dooms, Colin R Lindsay, Carlos Gil Ferreira, Normand Blais, Cynthia C Obiozor, Yang Wang, Bhakti Mehta, Tracy Varrieur, Gataree Ngarmchamnanrith, Björn Stollenwerk, David Waterhouse*, Luis Paz-Ares*, for the CodeBreaK 200 Investigators
doi : 10.1016/S0140-6736(23)00221-0
Volume 401, Issue 10378, 4–10 March 2023, Pages 733-746
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Alexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, Ziad Reguiai, Alice B Gottlieb, Falk G Bechara, Carle Paul, Evangelos J Giamarellos Bourboulis, Axel P Villani, Andreas Schwinn, Franziska Ruëff, Larisha Pillay Ramaya, Adam Reich, Ines Lobo, Rodney Sinclair, Thierry Passeron, Antonio Martorell, Pedro Mendes-Bastos, Georgios Kokolakis, Pierre-Andre Becherel, Magdalena B Wozniak, Angela Llobet Martinez, Xiaoling Wei, Lorenz Uhlmann, Anna Passera, Deborah Keefe, Ruvie Martin, Clarice Field, Li Chen, Marc Vandemeulebroecke, Shoba Ravichandran, Elisa Muscianisi
doi : 10.1016/S0140-6736(23)00022-3
Volume 401, Issue 10378, 4–10 March 2023, Pages 747-761
Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study
Tanja Schlaikjær Hartwig, Louise Ambye, Jennifer R Gruhn, Jesper Friis Petersen, Tine Wrønding, Letizia Amato, Andrew Chi-Ho Chan, Boyang Ji, Maiken Hemme Bro-Jørgensen, Lene Werge, Mette Marie Babiel Schmidt Petersen, Clara Brinkmann, Julie Birch Petersen, Morten Dunø, Iben Bache, Markus J Herrgård, Finn Stener Jørgensen, Eva R Hoffmann, Henriette Svarre Nielsen, and the COPL consortium
doi : 10.1016/S0140-6736(22)02610-1
Volume 401, Issue 10378, 4–10 March 2023, Pages 762-771
Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab
Denis O’Mahony, Stephen P Power, Derek G Power
doi : 10.1016/S0140-6736(23)00141-1
Volume 401, Issue 10378, 4–10 March 2023, Page 772
Acute aortic dissection
Thierry Carrel, Thoralf M Sundt 3rd, Yskert von Kodolitsch, Martin Czerny
doi : 10.1016/S0140-6736(22)01970-5
Volume 401, Issue 10378, 4–10 March 2023, Pages 773-788
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent
Thierry Lefrançois*, Denis Malvy*, Laetitia Atlani-Duault, Daniel Benamouzig, Pierre-Louis Druais, Yazdan Yazdanpanah, Jean-François Delfraissy, Bruno Lina
doi : 10.1016/S0140-6736(22)01840-2
Volume 401, Issue 10378, 4–10 March 2023, Pages 789-794
